311 related articles for article (PubMed ID: 21847703)
1. Rituximab as a new therapeutic option in granulomatosis with polyangiitis: a report of two cases.
Dalkilic E; Alkis N; Kamali S
Mod Rheumatol; 2012 Jun; 22(3):463-6. PubMed ID: 21847703
[TBL] [Abstract][Full Text] [Related]
2. Refractory Wegener's granulomatosis: effect of rituximab on granulomatous bilateral orbital involvement.
Avshovich N; Boulman N; Slobodin G; Zeina AR; Rosner I; Rozenbaum M
Isr Med Assoc J; 2009 Sep; 11(9):566-8. PubMed ID: 19960854
[No Abstract] [Full Text] [Related]
3. Treatment of refractory retrobulbar granuloma with rituximab in a patient with ANCA-negative Wegener's granulomatosis: a case report.
Ooka S; Maeda A; Ito H; Omata M; Yamada H; Ozaki S
Mod Rheumatol; 2009; 19(1):80-3. PubMed ID: 18806927
[TBL] [Abstract][Full Text] [Related]
4. Sustained 3-year remission after rituximab treatment in a patient with refractory Wegener's granulomatosis.
Tektonidou MG; Skopouli FN
Clin Exp Rheumatol; 2006; 24(2 Suppl 41):S103. PubMed ID: 16859607
[No Abstract] [Full Text] [Related]
5. Adjunction of rituximab to steroids and immunosuppressants for refractory/relapsing Wegener's granulomatosis: a study on 8 patients.
Brihaye B; Aouba A; Pagnoux C; Cohen P; Lacassin F; Guillevin L
Clin Exp Rheumatol; 2007; 25(1 Suppl 44):S23-7. PubMed ID: 17428359
[TBL] [Abstract][Full Text] [Related]
6. Rituximab in refractory ophthalmic Wegener's granulomatosis: PR3 titers may predict relapse, but repeat treatment can be effective.
Joshi L; Lightman SL; Salama AD; Shirodkar AL; Pusey CD; Taylor SR
Ophthalmology; 2011 Dec; 118(12):2498-503. PubMed ID: 21907416
[TBL] [Abstract][Full Text] [Related]
7. Rituximab for induction and maintenance therapy in granulomatosis with polyangiitis (Wegener's). Results of a single-center cohort study on 66 patients.
Calich AL; Puéchal X; Pugnet G; London J; Terrier B; Charles P; Mouthon L; Guillevin L;
J Autoimmun; 2014 May; 50():135-41. PubMed ID: 24703438
[TBL] [Abstract][Full Text] [Related]
8. Rituximab in the treatment of refractory scleritis in patients with granulomatosis with polyangiitis (Wegener's).
Recillas-Gispert C; Serna-Ojeda JC; Flores-Suárez LF
Graefes Arch Clin Exp Ophthalmol; 2015 Dec; 253(12):2279-84. PubMed ID: 26507398
[TBL] [Abstract][Full Text] [Related]
9. Rituximab with or without a conventional maintenance agent in the treatment of relapsing granulomatosis with polyangiitis (Wegener's): a retrospective single-center study.
Azar L; Springer J; Langford CA; Hoffman GS
Arthritis Rheumatol; 2014 Oct; 66(10):2862-70. PubMed ID: 24943239
[TBL] [Abstract][Full Text] [Related]
10. Nine patients with anti-neutrophil cytoplasmic antibody-positive vasculitis successfully treated with rituximab.
Eriksson P
J Intern Med; 2005 Jun; 257(6):540-8. PubMed ID: 15910558
[TBL] [Abstract][Full Text] [Related]
11. Treatment of orbital inflammation with rituximab in Wegener's granulomatosis.
Baslund B; Wiencke AK; Rasmussen N; Faurschou M; Toft PB
Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S7-10. PubMed ID: 22272561
[TBL] [Abstract][Full Text] [Related]
12. S3. Rituximab for ANCA-associated vasculitides: the French experience.
Charles P; Guillevin L
Presse Med; 2013 Apr; 42(4 Pt 2):534-6. PubMed ID: 23453207
[No Abstract] [Full Text] [Related]
13. Treatment of granulomatosis with polyangiitis (Wegener's).
Pagnoux C; Guillevin L
Expert Rev Clin Immunol; 2015 Mar; 11(3):339-48. PubMed ID: 25644677
[TBL] [Abstract][Full Text] [Related]
14. Refractory pituitary granulomatosis with polyangiitis (Wegener's) treated with rituximab.
Hughes J; Barkhoudarian G; Ciarlini P; Laws ER; Mody E; Inzucchi SE; Woodmansee WW
Endocr Pract; 2013; 19(1):e1-7. PubMed ID: 23186961
[TBL] [Abstract][Full Text] [Related]
15. Rituximab therapy for Wegener's granulomatosis refractory to conventional treatment.
Sánchez-Escuredo A; Núñez R; Ibernón M; Martínez E; López D; Navarro M; Bonet J; Ara J; Romero R
Nefrologia; 2011; 31(4):502-4. PubMed ID: 21738261
[No Abstract] [Full Text] [Related]
16. Wegener's granulomatosis effectively treated with rituximab: a case study.
Kowalewska B; Szechiński J; Roszkowska E
Pol Arch Med Wewn; 2008 Jun; 118(6):381-5. PubMed ID: 18619196
[TBL] [Abstract][Full Text] [Related]
17. Granulomatosis and polyangiitis: the rituximab option.
Polachek A; Caspi D; Elkayam O
Isr Med Assoc J; 2013 Mar; 15(3):193-4. PubMed ID: 23662388
[No Abstract] [Full Text] [Related]
18. Refractory Wegener's granulomatosis presenting with alveolar haemorrhage, treated with rituximab.
Caetano J; Fernandes das Neves M; Oliveira S; Delgado Alves J
BMJ Case Rep; 2014 Dec; 2014():. PubMed ID: 25519869
[No Abstract] [Full Text] [Related]
19. Lower doses of rituximab in remission induction for refractory granulomatosis with polyangiitis.
Wawrzycka-Adamczyk K; Zugaj A; Włudarczyk A; Kosałka J; Sznajd J; Bazan-Socha S; Musiał J
Przegl Lek; 2014; 71(12):663-5. PubMed ID: 25951692
[TBL] [Abstract][Full Text] [Related]
20. Rituximab (MABTHERA) and severe polyangiitis. An option for patients informed of the uncertainties.
Prescrire Int; 2015 Jun; 24(161):145-8. PubMed ID: 26436161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
